Overall result forecast presentation:	yes
Quantity performed reporting year:	100
Quantity forecast year:	101
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: no

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
38	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
8	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
8	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

Advice on prevention and intervention in cases of violence and abuse

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? Yes
Measures
- Intervention
  Intervention plan - Binding procedure for dealing with child protection cases and in particular suspected (sexual) violence
  Last review of the measure
  01.05.2021 20:15:57
- Review
  Recommendations for dealing with/processing cases that have occurred
  Last review of the measure
  01.05.2021 20:15:57

Commentary on the protection concept

Gemäß Teil A § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß Teil A § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Electronic support for the supply of patients with drugs

Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)

Electronic documentation of the administration of drugs

Measures to minimise medication errors

Fallbesprechungen
Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)

Measures to ensure seamless drug therapy after discharge

Aushändigung des Medikationsplans
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

FL03 - Student training (clinical traineeship / internship year)

Explanation

FL04 - Project-related cooperation with colleges and universities

Explanation

FL08 - Editors of scientific journals/textbooks

Explanation

FL09 - Doctoral supervision

Explanation

Training

Training in other healing professions

HB19 - Nursing professionals

Comment

HB17 - Auxiliary nurse (m/f)

Comment

HB05 - Medical technical radiology assistant (MTRA) (m/f)

Comment

HB07 - Surgical technical assistant (m/f)

Comment

Hospital staff
Pharmaceutical personnel
- Number of pharmacists: 4
- Additional staff: 25
- Explanations: Versorgung durch eine externe Apotheke
- Nursing staff regulation

Service contact persons

Patient advocates

Angelika Reimer

Patientenfürsprecherin

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08261 -797-6402
Mail: ed.ueaglla-dnubrevkinilk@remier.akilegna

Customer feedback management

Ralph Czeschner

Pflegeexperte

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08261 -797-6410
Mail: ed.ueaglla-dnubrevkinilk@renhcsezc.hplar

Quality management

Jeannine Hsain

Leitung Organisationsentwicklung, Prozesse und Digitalisierung (OPD)

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08323 -910-8791
Mail: ed.ueaglla-dnubrevkinilk@niash.eninnaej

Responsible for drug therapy

Dr. med. Mattias Sauter

Vositzender Arzneimittelkommission, Leiter Hygiene und Infektiologie Klinikverbund Allgäu

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 0831 -530-1809
Mail: ed.ueaglla-dnubrevkinilk@retuas.saihttam

Accessibility Officer

Ralph Czeschner

Pflegeexperte

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08261 -797-6410
Mail: ed.ueaglla-dnubrevkinilk@renhcsezc.hplar

Company

General contact details of the hospital

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08261-797-0
Mail: ed.ueaglla-dnubrevkinilk@ofni

Nursing service management

Stanislav Koren

Pflegedirektor Klinik Mindelheim und Ottobeuren

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08261 -797-7130
Mail: ed.ueaglla-dnubrevkinilk@nerok.valsinats

Sven Sünram

Pflegedienstleiter Klinik Mindelheim

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08261 -797-6130
Mail: ed.ueaglla-dnubrevkinilk@marneus.nevs

Head of administration

Anna Maria Egger

Betriebsleitung Klinik Mindelheim

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08261 -797-7169
Mail: ed.ueaglla-dnubrevkinilk@regge.anna

Jochen Duss

Kaufmännischer Leiter Infrastruktur und Prokurist Klinikverbund Allgäu

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 0831 -530-3550
Mail: ed.ueaglla-dnubrevkinilk@ssud.nehcoj

Andreas Ruland

Vorsitzender Geschäftsführer Klinikverbund Allgäu

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08323 -910-244
Mail: ed.ueaglla-dnubrevkinilk@dnalur.saerdna

Michael Osberghaus

Stellv. Vorsitzender Geschäftsführer Klinikverbund Allgäu

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 0831 -530-3220
Mail: ed.ueaglla-dnubrevkinilk@suahgrebso.leahcim

Florian Glück

Geschäftsführer Klinikverbund Allgäu, Standort-Geschäftsführer Klinik Mindelheim bis 31.01.2025

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08261 -797-7127
Mail: ed.ueaglla-dnubrevkinilk@kceulg.nairolf

Marie Demuth

Geschäftsführerin Klinikverbund Allgäu, Standort-Geschäftsführerin Klinik Mindelheim seit 01.02.2025

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08261 -797-7127
Mail: ed.ueaglla-dnubrevkinilk@htumed.eiram

Markus Treffler

Kaufmännischer Leiter Finanzen und Prokurist Klinikverbund Allgäu bis 30.04.2025

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08323 -910-244
Mail: ed.ueaglla-dnubrevkinilk@relffert.sukram

Responsible for the quality report in the hospital management

Marie Demuth

Geschäftsführerin

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08261 -797-7127
Mail: ed.ueaglla-dnubrevkinilk@htumed.eiram

Medical management

PD Dr. med. Peter Steinbigler

Ärztlicher Direktor Klinik Mindelheim bis 31.03.2025

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08261 -797-7640
Mail: ed.ueaglla-dnubrevinilk@relgibniets.retep

Dr. med. Manfred Nuscheler

Ärztlicher Direktor Klinik Mindelheim seit 01.04.2025

Bad Wörishofer Straße 44
87719 Mindelheim

Phone: 08261 -797-6142
Mail: ed.ueaglla-dnubrevkinilk@relehcsun.derfnam

IK number

IK: 260971210

Location number

Location number: 773547000

Hospital portrait for download